- PowerScore Staff
- Posts: 8916
- Joined: Feb 02, 2011
- Fri Jul 15, 2016 11:21 am
#27233
Passage A Overview:
The author of this first passage discusses antibiotic resistance, which allows bacteria to survive antibiotics, and some contributing factors (including over-prescription, food additive use, and rapid plasma transfer) which can allow some resistant bacteria populations to form within days. New antibiotics used to be created to keep pace with the new bacteria, but now such creation is less profitable than other drugs. The author presents the bleak conclusion of this passage in the final sentence: it seems extremely likely that effective antibiotics will no longer be available to treat seriously ill patients in the near future. This conclusion is based on three causes: decreased antibiotic industry production, government inaction, and the increasing number of resistant bacteria.
Passage B Overview:
The author of Passage B also discusses the problem of antibiotic resistance, but the main point in this case is to present and describe several possible alternatives to antibiotics: Vaccines, which enhance the body’s natural defenses, bacteriophages, which cause bacteria to “self-destruct,” and localized bioactive phytochemicals, which inhibit bacteria growth in humans with minimal effects from existing antibiotic resistance.
Passages Compared:
Both authors introduce the problem of antibiotic resistance, but their perspectives on the matter are very clearly distinguishable. The author of Passage A takes a much more pessimistic tone, listing some of the reasons for the problem, and concluding that for some in the future, there will likely be no solution. The more optimistic author of Passage B, in stark contrast, focuses less on the problem, instead choosing to introduce and describe three possible solutions.
The author of this first passage discusses antibiotic resistance, which allows bacteria to survive antibiotics, and some contributing factors (including over-prescription, food additive use, and rapid plasma transfer) which can allow some resistant bacteria populations to form within days. New antibiotics used to be created to keep pace with the new bacteria, but now such creation is less profitable than other drugs. The author presents the bleak conclusion of this passage in the final sentence: it seems extremely likely that effective antibiotics will no longer be available to treat seriously ill patients in the near future. This conclusion is based on three causes: decreased antibiotic industry production, government inaction, and the increasing number of resistant bacteria.
Passage B Overview:
The author of Passage B also discusses the problem of antibiotic resistance, but the main point in this case is to present and describe several possible alternatives to antibiotics: Vaccines, which enhance the body’s natural defenses, bacteriophages, which cause bacteria to “self-destruct,” and localized bioactive phytochemicals, which inhibit bacteria growth in humans with minimal effects from existing antibiotic resistance.
Passages Compared:
Both authors introduce the problem of antibiotic resistance, but their perspectives on the matter are very clearly distinguishable. The author of Passage A takes a much more pessimistic tone, listing some of the reasons for the problem, and concluding that for some in the future, there will likely be no solution. The more optimistic author of Passage B, in stark contrast, focuses less on the problem, instead choosing to introduce and describe three possible solutions.
